Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Downgrades Neovasc to Neutral

HC Wainwright & Co. Downgrades Neovasc to Neutral

HC Wainwright & Co. analyst Vernon Bernardino downgrades Neovasc (NASDAQ:NVCN) from Buy to Neutral.

byBenzinga Newsdesk

January 18, 2023

1 minute read

HC Wainwright & Co. analyst Vernon Bernardino downgrades Neovasc (NASDAQ:NVCN) from Buy to Neutral.

News

First Wave BioPharma Announces Private Placement

By Benzinga Newsdesk

July 15, 8:07 AM

First Wave BioPharma, Inc. Announces Private Placement BOCA RATON, Fla., July 15, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) ("First Wave BioPharma" or the "Company"), a

FWBI

Analyst Ratings

Where Duolingo Stands With Analysts

By Benzinga Insights

October 13, 2:00 PM

Duolingo (NASDAQ:DUOL) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

DUOL

Deutsche Bank Maintains Buy on Chewy, Lowers Price Target to $41

By Benzinga Newsdesk

Today, 12:56 PM

Deutsche Bank analyst Lee Horowitz maintains Chewy (NYSE:CHWY) with a Buy and lowers the price target from $51 to $41.

CHWY

This AI Stock Is Up 254% Year-To-Date — And It’s Not Nvidia

By Surbhi Jain

April 1, 11:53 AM

Investors expect Nvidia to the S&P 500 pack, but Super Micro Computer is outshining the semiconductor giant.

AMD

HC Wainwright & Co. Downgrades Neovasc to Neutral

Related Posts

First Wave BioPharma Announces Private Placement

Where Duolingo Stands With Analysts

Deutsche Bank Maintains Buy on Chewy, Lowers Price Target to $41

This AI Stock Is Up 254% Year-To-Date — And It’s Not Nvidia